| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| CN¥0.40 | -20% | ||
| CN¥0.40 | -20% | ||
| CN¥0.50 | -16.67% | ||
| CN¥0.50 | -16.67% | ||
| CN¥0.60 | 0% | ||
| CN¥0.60 | 33.33% | ||
| CN¥0.45 | 50% | ||
| CN¥0.30 | 20% | ||
| CN¥0.25 | 0% | ||
| CN¥0.25 | |||
Zhejiang Xinguang Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 2.72%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XSHE
- Value
- €1.83
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Zhejiang Xinguang Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.40. For the next 12 months, Zhejiang Xinguang Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.40. This corresponds to a dividend yield of approximately 2.72%.
- The dividend yield of Zhejiang Xinguang Pharmaceutical Co Ltd Class A is currently 2.72%.
- Zhejiang Xinguang Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in May.
- The next dividend for Zhejiang Xinguang Pharmaceutical Co Ltd Class A is expected in May.
- Within the last 10 years, Zhejiang Xinguang Pharmaceutical Co Ltd Class A has paid dividends in 8 of them.
- Dividends of CN¥0.40 are expected for the next 12 months. This corresponds to a dividend yield of 2.72%.
- Zhejiang Xinguang Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Zhejiang Xinguang Pharmaceutical Co Ltd Class A was on 4 July 2017 in the ratio 20:10.
- To receive the last dividend of Zhejiang Xinguang Pharmaceutical Co Ltd Class A on 29 May 2024 in the amount of CN¥0.40 you had to have the stock in your portfolio before the ex-day on 29 May 2024.
- The last dividend was paid on 29 May 2024.
- In 2022, dividends of CN¥0.60 were paid by Zhejiang Xinguang Pharmaceutical Co Ltd Class A.
- Dividends from Zhejiang Xinguang Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Zhejiang Xinguang Pharmaceutical Co Ltd Class A is located in China.